| NKG2D ligands mediate immunosurveillance of senescent cells A Sagiv, DGA Burton, Z Moshayev, E Vadai, F Wensveen, S Ben-Dor, ... Aging (Albany NY) 8 (2), 328, 2016 | 275 | 2016 |
| Physiological and pathological consequences of cellular senescence DGA Burton, V Krizhanovsky Cellular and Molecular Life Sciences 71, 4373-4386, 2014 | 256 | 2014 |
| Cellular senescence: immunosurveillance and future immunotherapy DGA Burton, A Stolzing Ageing research reviews 43, 17-25, 2018 | 182 | 2018 |
| Cellular senescence, ageing and disease DGA Burton Age 31 (1), 1-9, 2009 | 172 | 2009 |
| Lipid (per) oxidation in mitochondria: an emerging target in the ageing process? OS Ademowo, HKI Dias, DGA Burton, HR Griffiths Biogerontology 18 (6), 859-879, 2017 | 170 | 2017 |
| Senescent cells communicate via intercellular protein transfer A Biran, M Perelmutter, H Gal, DGA Burton, Y Ovadya, E Vadai, T Geiger, ... Genes & development 29 (8), 791-802, 2015 | 156 | 2015 |
| Obesity and type-2 diabetes as inducers of premature cellular senescence and ageing DGA Burton, RGA Faragher Biogerontology 19 (6), 447-459, 2018 | 147 | 2018 |
| Pathophysiology of vascular calcification: pivotal role of cellular senescence in vascular smooth muscle cells DGA Burton, H Matsubara, K Ikeda Experimental gerontology 45 (11), 819-824, 2010 | 141 | 2010 |
| Microarray analysis of senescent vascular smooth muscle cells: a link to atherosclerosis and vascular calcification DGA Burton, PJ Giles, ANP Sheerin, SK Smith, JJ Lawton, EL Ostler, ... Experimental gerontology 44 (10), 659-665, 2009 | 136 | 2009 |
| Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic RAS-induced DNA damage and premature senescence P Rai, JJ Young, DGA Burton, MG Giribaldi, TT Onder, RA Weinberg Oncogene 30 (12), 1489-1496, 2011 | 134 | 2011 |
| MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways A Patel, DGA Burton, K Halvorsen, W Balkan, T Reiner, C Perez-Stable, ... Oncogene 34 (20), 2586-2596, 2015 | 106 | 2015 |
| Cellular senescence: from growth arrest to immunogenic conversion DGA Burton, RGA Faragher Age 37, 1-19, 2015 | 102 | 2015 |
| Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells DGA Burton, MG Giribaldi, A Munoz, K Halvorsen, A Patel, M Jorda, ... PloS one 8 (6), e68003, 2013 | 68 | 2013 |
| Cyclin D1 overexpression permits the reproducible detection of senescent human vascular smooth muscle cells DGA Burton, AN Sheerin, EL Ostler, K Smith, PJ Giles, J Lowe, ... Annals of the New York Academy of Sciences 1119 (1), 20-31, 2007 | 56 | 2007 |
| Bridging the gap: ageing, pharmacokinetics and pharmacodynamics DGA Burton, MC Allen, JLE Bird, RGA Faragher Journal of pharmacy and pharmacology 57 (6), 671-679, 2005 | 48 | 2005 |
| An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation EGFR inhibitors M Mancini, H Gal, N Gaborit, L Mazzeo, D Romaniello, TM Salame, ... EMBO Molecular Medicine 10 (2), 294-308, 2018 | 47 | 2018 |
| Resveratrol, but not dihydroresveratrol, induces premature senescence in primary human fibroblasts RGA Faragher, DGA Burton, P Majecha, NSY Fong, T Davis, A Sheerin, ... Age 33, 555-564, 2011 | 31 | 2011 |
| MTH1 counteracts oncogenic oxidative stress DGA Burton, P Rai Oncoscience 2 (10), 785, 2015 | 17 | 2015 |
| Camptothecin sensitivity in Werner syndrome fibroblasts as assessed by the COMET technique J Lowe, A Sheerin, K JENNERT‐BURSTON, D Burton, EL Ostler, J Bird, ... Annals of the New York Academy of Sciences 1019 (1), 256-259, 2004 | 16 | 2004 |
| Personalising nutrition for older adults: The InCluSilver project DGA Burton, C Wilmot, HR Griffiths Nutrition bulletin 43 (4), 442-455, 2018 | 9 | 2018 |
Valery KrizhanovskyWeizmann Institute of ScienceVerified email at weizmann.ac.il
